(Q45918889)

English

A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.

scientific article published in January 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

S. Vincent Rajkumar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

J A Katzmann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

1 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

27

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23299499%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Screening panels for detection of monoclonal gammopathies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

21 January 2018

A 71-year-old woman with multiple myeloma status after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.201

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45918889&oldid=2207456155"